Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
EPAD-AMYPAD imaging workshop
EPAD-AMYPAD imaging workshop 17 Jun 2021 The objectives of the workshop were to identify and establish possible collaborations.....
AMYPAD presents at the IMI event
AMYPAD presents at the IMI event "Impact on Dementia" 15 Jun 2021 Gill Farrar gave an overview of the AMYPAD project at the IMI Impact on Dementia event......
AMYPAD study cases presented at SNMMI 2021
AMYPAD study cases presented at SNMMI 2021 11 Jun 2021 Valentina Garibotto and Giovanni Frisoni explored interesting cases taken from the AMYPAD Diagnostic Study and highlighted the value of the close working relationship between......
Recruitment status (as 31 May, 2021)
Recruitment status (as 31 May, 2021)